http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110607400-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97651de1ceeb2411cad2574055776c20 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6841 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6841 |
| filingDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fffe988075b2652da75daf948d40e06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67410be0747e940931189137cd2462e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da4b2510f3a7210d097a8df08e63bda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ac734cc425e9a20f570496dffe382bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb08bfbfc180564efae889ae747e9ddb |
| publicationDate | 2019-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110607400-A |
| titleOfInvention | A tissue in situ hybridization diagnosis and detection system for BKV and its application |
| abstract | The present invention relates to the technical field of gene diagnosis, and specifically discloses an in situ nucleic acid diagnosis and detection system for BKV, including probes for detecting BKV, and the sequences of the probes are as shown in SEQ ID Nos: 1-40. The sequence shown or its complement. The invention also discloses the use of the system in preparing BKV diagnostic or detection reagents/kits. The BKV tissue in situ hybridization diagnosis and detection system of the present invention has high sensitivity and good specificity, can be used to accurately diagnose the activation of BKV to guide clinical symptomatic medication, and improve the sensitivity and specificity of BKV tissue diagnosis. The application of the BKV in situ hybridization technology of the present invention will greatly improve the sensitivity and specificity of BKV tissue diagnosis, reduce the harm caused by BKV-related diseases, and have broad market application prospects. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442553-A |
| priorityDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.